Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis

[1]  淳一 佐々木.  Air Force/Texas Coronary Atherosclerosis Prevention Study , 2008 .

[2]  S. Feasson,et al.  MRC/BHF heart protection study of cholesterol lowering with simvastatin in 20536 high-risk individuals : a randomised placebo-controlled trial. , 2008 .

[3]  T. Terano,et al.  Eicosapentaenoic acid suppressed the proliferation of vascular smooth muscle cells through modulation of various steps of growth signals , 2007, Lipids.

[4]  Yasuo Ohashi,et al.  Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial , 2006, The Lancet.

[5]  Y. Kokubo,et al.  Intake of Fish and n3 Fatty Acids and Risk of Coronary Heart Disease Among Japanese: The Japan Public Health Center-Based (JPHC) Study Cohort I , 2006, Circulation.

[6]  Philip J. Barter,et al.  Intensive lipid lowering with atorvastatin in patients with stable coronary disease. , 2005, The New England journal of medicine.

[7]  Neil J Stone,et al.  Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines , 2004, Circulation.

[8]  A. Dyer,et al.  Accumulated Evidence on Fish Consumption and Coronary Heart Disease Mortality: A Meta-Analysis of Cohort Studies , 2004, Circulation.

[9]  David E Newby,et al.  Omega 3 fatty acids and cardiovascular disease-- fishing for a natural treatment , 2003 .

[10]  J. Slattery,et al.  Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). 1994. , 1994, Atherosclerosis. Supplements.

[11]  Tomás Pantoja,et al.  Análisis crítico de un artículo Las estatinas reducen la morbi-mortalidad en pacientes de alto riesgo cardiovascular: Heart Protection Study Collaborative Group. (HPS). Lancet 2002; 360: 7-22. , 2003 .

[12]  H. Origasa,et al.  Effects of eicosapentaenoic acid on cardiovascular events in Japanese patients with hypercholesterolemia: rationale, design, and baseline characteristics of the Japan EPA Lipid Intervention Study (JELIS). , 2003, American heart journal.

[13]  J. Mehta,et al.  EPA and DHA attenuate ox-LDL-induced expression of adhesion molecules in human coronary artery endothelial cells via protein kinase B pathway. , 2003, Journal of molecular and cellular cardiology.

[14]  P. Calder,et al.  Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial , 2003, The Lancet.

[15]  D. Mozaffarian,et al.  n-3 Polyunsaturated fatty acids, fatal ischemic heart disease, and nonfatal myocardial infarction in older adults: the Cardiovascular Health Study. , 2003, The American journal of clinical nutrition.

[16]  W. Harris,et al.  Cardiovascular disease and long-chain omega-3 fatty acids , 2003, Current opinion in lipidology.

[17]  H. Sugihara,et al.  Serum fatty acid levels, dietary style and coronary heart disease in three neighbouring areas in Japan: the Kumihama study , 2003, British Journal of Nutrition.

[18]  Y. Matsuzawa,et al.  Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia. , 2002, Circulation journal : official journal of the Japanese Circulation Society.

[19]  T. Yano,et al.  Changes in aspects such as the collagenous fiber density and foam cell size of atherosclerotic lesions composed of foam cells, smooth muscle cells and fibrous components in rabbits caused by all-cis-5, 8, 11, 14, 17-icosapentaenoic acid. , 2002, Journal of atherosclerosis and thrombosis.

[20]  AndrewJ. S. Coats.  MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial , 2002, The Lancet.

[21]  J. Manson,et al.  Blood levels of long-chain n-3 fatty acids and the risk of sudden death. , 2002, The New England journal of medicine.

[22]  J. Manson,et al.  Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. , 2002, JAMA.

[23]  A. Leaf.  Prevention of Fatal Cardiac Arrhythmias by Polyunsaturated Fatty Acids , 2002, Nutrition and health.

[24]  S. Yusuf.  MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Commentary , 2002 .

[25]  P. Durrington,et al.  An omega-3 polyunsaturated fatty acid concentrate administered for one year decreased triglycerides in simvastatin treated patients with coronary heart disease and persisting hypertriglyceridaemia , 2001, Heart.

[26]  P. Calder,et al.  Dietary fish oil reduces intercellular adhesion molecule 1 and scavenger receptor expression on murine macrophages. , 2000, Atherosclerosis.

[27]  ichard,et al.  FISH CONSUMPTION AND THE 30-YEAR RISK OF FATAL MYOCARDIAL INFARCTION , 2000 .

[28]  H. Nihei,et al.  Eicosapentanoic acid reduces plasma levels of remnant lipoproteins and prevents in vivo peroxidation of LDL in dialysis patients. , 1999, Journal of the American Society of Nephrology : JASN.

[29]  GISSI-Prevenzione Investigators,et al.  Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial , 1999, The Lancet.

[30]  Roberto Marchioli,et al.  Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. , 1999 .

[31]  A. Satoh,et al.  Joint effects of HMG-CoA reductase inhibitors and eicosapentaenoic acids on serum lipid profile and plasma fatty acid concentrations in patients with hyperlipidemia , 1999, International journal of clinical & laboratory research.

[32]  T. Müller,et al.  Dietary omega-3, omega-6, and omega-9 unsaturated fatty acids and growth factor and cytokine gene expression in unstimulated and stimulated monocytes. A randomized volunteer study. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[33]  T. Müller,et al.  Dietary ω-3, ω-6, and ω-9 Unsaturated Fatty Acids and Growth Factor and Cytokine Gene Expression in Unstimulated and Stimulated Monocytes A Randomized Volunteer Study , 1999 .

[34]  N. Sheard.  Fish consumption and risk of sudden cardiac death. , 2009, Nutrition reviews.

[35]  A. Gotto,et al.  Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. , 1998, JAMA.

[36]  S. Miwa,et al.  2.P.62 Effect of eicosapentaenoic acid in combination with HMG-CoA reductase inhibitor on lipid metabolism , 1997 .

[37]  Y. Okuda,et al.  Eicosapentaenoic acid enhances nitric oxide production by cultured human endothelial cells. , 1997, Biochemical and biophysical research communications.

[38]  P. Macfarlane,et al.  West of Scotland Coronary Prevention Study: Identification of high-risk groups and comparison with other cardiovascular intervention trials , 1996 .

[39]  P. Macfarlane,et al.  Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia , 1995 .

[40]  T. Raghunathan,et al.  Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. , 1995, JAMA.

[41]  J. Strain,et al.  Dietary fish oil supplementation alters leukocyte function and cytokine production in healthy women. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[42]  P. Macfarlane,et al.  Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. , 1995, The New England journal of medicine.

[43]  Scandinavian Simvastatin Survival Study Group.  Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) , 1994, The Lancet.

[44]  T. Hedner,et al.  Prospective randomized open blinded end-point (PROBE) study. A novel design for intervention trials. Prospective Randomized Open Blinded End-Point. , 1992, Blood pressure.

[45]  Y. Matsuzawa,et al.  Effects of purified eicosapentaenoic acid ethyl ester on plasma lipoproteins in primary hypercholesterolemia. , 1992, International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition.

[46]  P. Elwood,et al.  EFFECTS OF CHANGES IN FAT, FISH, AND FIBRE INTAKES ON DEATH AND MYOCARDIAL REINFARCTION: DIET AND REINFARCTION TRIAL (DART) , 1989, The Lancet.

[47]  A. Folsom,et al.  Serum fatty acids and fish intake in rural Japanese, urban Japanese, Japanese American and Caucasian American men. , 1989, International journal of epidemiology.

[48]  H. Sewell,et al.  CYTOCHROME P-450 IMMUNOLOCALISATION IN HUMAN LIVER , 1986, The Lancet.

[49]  T. Terano,et al.  Clinical and epidemiological studies of eicosapentaenoic acid (EPA) in Japan. , 1986, Progress in lipid research.

[50]  D Kromhout,et al.  The inverse relation between fish consumption and 20-year mortality from coronary heart disease. , 1985, The New England journal of medicine.

[51]  J. Salmon,et al.  Effect of orally administered eicosapentaenoic acid (EPA) on the formation of leukotriene B4 and leukotriene B5 by rat leukocytes. , 1984, Biochemical pharmacology.

[52]  T. Hamazaki,et al.  The effects of the oral administration of fish oil concentrate on the release and the metabolism of [14C]arachidonic acid and [14C]eicosapentaenoic acid by human platelets. , 1982, Thrombosis research.

[53]  T. Hamazaki,et al.  Effects of orally administered ethyl ester of eicosapentaenoic acid (EPA; C20:5, omega-3) on PGI2-like substance production by rat aorta. , 1982, Prostaglandins.